Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor

Scientific Reports
Jeong-Sun SeoYoung Tae Kim


Characterizing the molecular immune subtype and micro-environment of lung cancer is necessary to understand immunogenic interactions between infiltrating immune and stromal cells, and how tumor cells overcome immune checkpoint blockades. This study seeks to identify computational methodologies for subtyping gene expression-based tumor-immune micro-environment interactions, which differentiate non-small cell lung cancer (NSCLC) into immune-defective and immune-competent subtypes. Here, 101 lung squamous cell carcinomas (LUSCs) and 87 lung adenocarcinomas (LUADs) tumor samples have been analyzed. Several micro-environmental factors differentially induce LUAD or LUSC immune subtypes, as well as immune checkpoint expression. In particular, tumor-associated macrophages (TAMs) are key immune cells play a vital role in inflammation and cancer micro-environments of LUSCs; whereas, regulatory B cells are immunosuppressive and tumorigenic in LUADs. Additionally, cytolytic activity upon CD8+ T cell activation is decreased by the abundance of B cells and macrophages in immune-competent subtypes. Therefore, identifying immune subtypes in lung cancer and their impact on tumor micro-environment will lead to clinical tools for assessing LUADs ...Continue Reading


Apr 14, 2020·Statistical Methods in Medical Research·Yang LiYifan Sun
Jun 18, 2020·Clinical & Translational Immunology·Menno TammingaHarry Jm Groen


Sep 18, 2008·International Journal of Cancer. Journal International Du Cancer·Silvia Goldoni, Renato V Iozzo
Jul 29, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Renat ShaykhievRonald G Crystal
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
Aug 6, 2010·Seminars in Radiation Oncology·Edward E GravesQuynh-Thu Le
Oct 29, 2010·Genome Biology·Simon Anders, Wolfgang Huber
Jan 10, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Natasha RekhtmanMarc Ladanyi
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Sep 15, 2012·Genome Research·Jeong-Sun SeoYoung Tae Kim
Oct 12, 2013·Nature Communications·Kosuke YoshiharaRoel G W Verhaak
Jul 11, 2014·Nature·Bart GhesquièrePeter Carmeliet
Jul 16, 2015·Cancer Biology & Medicine·Mariacarmela Santarpia, Niki Karachaliou
Oct 17, 2015·Nature Reviews. Immunology·Shannon J TurleyJillian L Astarita
Feb 26, 2016·Nature·Peter BaileySean M Grimmond
Apr 12, 2016·Tuberculosis and Respiratory Diseases·Ji Young Park, Seung Hun Jang
Jul 21, 2016·Journal for Immunotherapy of Cancer·Marc SchwartzJoseph D Rosenblatt
Aug 16, 2016·Breast Cancer Research : BCR·Karen M BussardFrank C Marini
Aug 18, 2016·Journal for Immunotherapy of Cancer·Claud Grigg, Naiyer A Rizvi
Aug 31, 2016·OncoTargets and Therapy·Hazem El-OstaPrakash Peddi
Sep 28, 2016·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Aesun ShinJin-Soo Lee
Nov 24, 2016·Oncotarget·Xiaosheng Wang, Qingrong Sun
Dec 23, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David BalliRobert H Vonderheide
May 19, 2017·Journal for Immunotherapy of Cancer·Sacha GnjaticLisa H Butterfield
Jun 14, 2017·Cancer Cell·Gabriel Abril-Rodriguez, Antoni Ribas
Jun 20, 2017·Cellular & Molecular Immunology·Anushruti SarvariaAurore Saudemont
Jun 24, 2017·Frontiers in Immunology·Sebastian Diegeler, Christine E Hellweg
Jul 11, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bhargavi PulluriSrinath Sundararajan
Oct 24, 2017·Nature Communications·Dvir AranAtul J Butte
Jan 11, 2018·British Journal of Cancer·Russell W JenkinsKeith T Flaherty
Feb 1, 2018·Therapeutic Advances in Medical Oncology·Irene Moya-HornoRafael Rosell
Apr 10, 2018·Cellular & Molecular Immunology·Si-Si WangLi Zhang

Related Concepts

Pathologic Cytolysis
Tumor Cells, Uncertain Whether Benign or Malignant
Adenocarcinoma of Lung (Disorder)
Tumor Immunity
Immune Effector Cell
Cancer Microenvironment
Neoplastic Cell

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.